News | Infection Update

NEWS

Highly antimicrobial-resistant bacteria increase severity and mortality in patients with intensive care unit-acquired pneumonia

16 September, 2021

Antimicrobial resistance is a growing global health concern. The spread of antimicrobial resistant (AMR) pathogens means that the treatment of common infections is becoming increasingly complicated.1 Despite this, there remains...

Antimicrobial resistance is a growing global health concern. The spread of antimicrobial resistant (AMR) pathogens means that the treatment of common infections is becoming increasingly complicated.1 Despite this, there remains...

COVID-19 post-infection immunity persists for at least 9 months

23 August, 2021

In most patients who have been infected with severe acute respiratory syndrome (SARS-CoV-2), the virus that causes COVID-19, antibody responses can be detected in their sera 10–15 days from the...

In most patients who have been infected with severe acute respiratory syndrome (SARS-CoV-2), the virus that causes COVID-19, antibody responses can be detected in their sera 10–15 days from the...

Tofacitinib lowered mortality risk in patients hospitalised with COVID-19 pneumonia

Disease progression in COVID-19 is associated with an impaired immune response, which leads to a cytokine release syndrome, or hyperinflammatory state.1 Treatment or management of this response could improve disease...

Disease progression in COVID-19 is associated with an impaired immune response, which leads to a cytokine release syndrome, or hyperinflammatory state.1 Treatment or management of this response could improve disease...

Bacterial coinfection found to be prevalent among hospitalised patients with community acquired pneumonia and flu

Influenza (or flu) is a contagious viral infection of the respiratory tract.1 It is estimated that over five million hospitalisations per annum worldwide are associated with influenza viruses, with the...

Influenza (or flu) is a contagious viral infection of the respiratory tract.1 It is estimated that over five million hospitalisations per annum worldwide are associated with influenza viruses, with the...

Understanding breakthrough COVID infections among vaccinated individuals

The rapid spread of the COVID-19 pandemic prompted an immense effort in the scientific community, leading to the development of over 300 vaccine projects.1 Currently, three vaccines have been approved...

The rapid spread of the COVID-19 pandemic prompted an immense effort in the scientific community, leading to the development of over 300 vaccine projects.1 Currently, three vaccines have been approved...

IDSA updates to treatment guidelines for COVID-19

The COVID-19 pandemic – caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – has taken the world by storm since the first outbreak in late December 2019 in...

The COVID-19 pandemic – caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – has taken the world by storm since the first outbreak in late December 2019 in...

2020 updated guidelines for urological infections

Urological infections, or urinary tract infections (UTIs) are one of the most frequently occurring infections worldwide. While 50% to 60% of adult women have experienced a UTI at least once...

Urological infections, or urinary tract infections (UTIs) are one of the most frequently occurring infections worldwide. While 50% to 60% of adult women have experienced a UTI at least once...

CDC updates treatment guidelines for gonococcal infection

09 February, 2021

Gonorrhoea – caused by infection with the Neisseria gonorrhoeae bacterium – affects approximately 106.1 million people annually, with rates of infection increasing steadily over the last few years.1-4 While the...

Gonorrhoea – caused by infection with the Neisseria gonorrhoeae bacterium – affects approximately 106.1 million people annually, with rates of infection increasing steadily over the last few years.1-4 While the...

Routine molecular point-of-care testing improves influenza detection in hospitalised adults

14 January, 2021

The multicentre, open-label, randomised controlled trial evaluating the molecular point-of-care test-and-treat strategy for influenza (FluPOC) has shown that the routine use of this strategy improves influenza detection and other clinical...

The multicentre, open-label, randomised controlled trial evaluating the molecular point-of-care test-and-treat strategy for influenza (FluPOC) has shown that the routine use of this strategy improves influenza detection and other clinical...

CDC updates recommendations for Staphylococcus aureus in NICU

30 November, 2020

Staphylococcus aureus remains a frequent source of infection in neonates, particularly affecting premature and critically ill infants.1 While infants may acquire S. aureus as part of their normal developing microbiota,...

Staphylococcus aureus remains a frequent source of infection in neonates, particularly affecting premature and critically ill infants.1 While infants may acquire S. aureus as part of their normal developing microbiota,...

LATEST TOPICS